On May 24, 2018, GSK and Servier signed an agreement to launch the manufacturing of innovative HIV drug Tivicay® (INN: dolutegravir) in the production facility of Servier Rus pharmaceutical plant in Moscow.
Under the terms of agreement, the full-cycle manufacturing of finished dosage form will be launched no later than May 2019.
Dolutegravir is designed to treat HIV infection in combination with other antiretroviral drugs. It was approved for use in Russia in 2014 and, since 2018, was included in the list of vital and essential drugs.
The parties have already implemented the technology transfer, transfer of analytical methods, manufactured pilot batches, and conducted the required testing and relevant registration procedures. Regulatory approval of Servier Rus as a Russian production site for manufacturing the drug is expected to be completed in 2018.
The agreement is signed for 5 years, starting from the production of first commercial batches. The basic manufacturing plan established by the agreement provides for the output of one million packages with possibility of further increase, which will fully meet a demand for this drug in Russia.
April 19-20, 2018, VII Cbonds Emerging Markets Bond Conference will take place in London. EM capital markets of Russia, CIS, Ukraine, Caucasus region, Africa, Middle East, Latin America, Asia, CEE will be in focus fof upcoming Conference.
Conference has been the most engaging event connected to EM capital markets and bringing together professional’s expertise. The key sessions are attended by reputed macroanalysts, portfolio managers, issuers, heads of DCM teams, who share their predictions on capital market conditions and discuss up-to-date investment ideas in the fixed income markets of Africa, Middle East, Latin America, Asia, CEE, Ukraine, Russia, CIS and Caucasus region.
The list of participants includes UK financial institutions, EM financial institutions and corporations, international rating agencies and infrastructure companies.
Cbonds Emerging Markets Bond Conference is the established annual meeting place for anyone involved in EM bond markets.
FOOD&DRINK Expo provides the excellent opportunity to meet the Russian flagship pasta brand MAKFA! FOOD&DRINK Expo will take place in Birmingham on April 16-18, 2018.
MAKFA – Russia’s largest exporter of pasta products in 25 countries in Europe, Asia, North and South America, CIS. The presence at international trade fairs reinforces the image of MAKFA and allows buyers and distributors to see with their own eyes exactly what the company is doing. MAKFA’s top-quality products will be displayed at FOOD&DRINK Expo – stand G170!
Company Profile 2018_MAKFA
Visit MAKFA: http://www.makfapasta.com/ http://www.makfahealth.com/
The UK Food Shows offer an unparalleled meeting point for the entire food and drink community – a first up fixture in every food professional’s diary. Five shows covering the complete UK supply chain – Food & Drink Expo, Foodex, The Ingredients Show, National Convenience Show and Farm Shop & Deli Show.
Buyers and decision makers across the whole industry, from grocery, wholesale and speciality retail to foodservice, ingredients and manufacturing, will come together to uncover the hottest trends, latest product launches and the industry’s vision for the future. These events promise three days of innovation, inspiration and theatre. This opportunity only comes once every two years.
Official website: https://www.foodanddrinkexpo.co.uk/